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Background: Advanced ovarian cancer (AOC) requires an aggressive surgery with large 
visceral resections in order to achieve an optimal or complete cytoreduction and increase the 
patient’s survival. However, the surgical aggressiveness in the treatment of AOC is not 
exempt from major complications, such as the gastrointestinal fistula (GIF), which stands out 
among others due to its high morbidity and mortality.
Methods: We evaluated the clinicopathological features in patients with AOC and their 
association with GI. Data for 107 patients with AOC who underwent primary debulking 
surgery were analyzed retrospectively. Clinicopathological features, including demographic, 
surgical procedures and follow-up data, were analyzed in relation to GIF.
Results: GIF was present in 11% of patients in the study, 5 (4.5%) and 7 (6.4%) of 
colorectal and small bowel origin, respectively. GIF was significantly associated with 
peritoneal cancer index (PCI) >20, more than 2 visceral resections, and multiple digestive 
resections. Overall and disease-free survival were also associated with GIF. Multivariate 
analysis identified partial bowel obstruction and operative bleeding as independent prognos-
tic factors for survival. The presence of GIF is positively associated with poor prognosis in 
patients with AOC.
Conclusion: Given the importance of successful cytoreductive surgery in AOC, the assess-
ment of the amount of tumor and the aggressiveness of the surgery to avoid the occurrence of 
GIF become a priority in patients with AOC.
Keywords: advanced ovarian cancer surgery, complications, intestinal leakage, intestinal 
fistula
Introduction
According to the Spanish Society against Cancer (AECC), ovarian cancer is usually 
diagnosed between 45 and 75 years of age, and up to 75% of the cases are diagnosed in 
advanced stages, resulting in a poor prognosis. In 2016, there were approximately 3412 
cases of ovarian cancer in Spain, 1960 of those case were lethal.1 However, the 
introduction of advanced ovarian cancer (AOC) surgery, which strives to achieve 
complete cytoreduction, aims to increase survival and provide a definitive cure in 
some cases.2 Such surgery is considered highly aggressive and often results in serious 
postoperative complications that could reach a rate of 38% reported in some systematic 
revisions and may cause an increase in patient mortality and the delay or impossibility 
of adjuvant oncological treatment.3 A multidisciplinary approach of AOC has been 
implemented by the Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery 
(MUAPOS), at the General University Hospital in Castellon since 2013 and was able to 
increase the patients’ survival in the past few years.4 An effort has been made in order 
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to identify risk and prognostic factors retrospectively in 
patients who suffered complications, for instance, gastroin-
testinal fistulae, creating a predictive model for major com-
plications after extensively primary debulking in order to 
predict morbidity. The study concluded that risk factors for 
major complications are: five or more visceral resections, 
rectosigmoid resection, glossectomy, and pelvic 
peritonectomy.5 We have currently taken a particular interest 
in the gastrointestinal fistulae (GIF), one of the most feared 
adverse events of extensive cytoreduction since rectosig-
moid, jejunum and/or ileum resections are necessary for 
approximately 50% of the AOC surgeries.5 Some factors 
favor the occurrence of digestive fistula, in the immediate 
or late postoperative period, such as hydroelectric imbalance 
and malnutrition, in addition to the intestinal resection and/or 
neoadjuvant chemotherapy. This usually leads to aggressive 
treatments and prolonged hospitalizations.6–9
The objective of this study is twofold, to address the 
results concerning the GIF collected at the MUAPOS at 
the General University Hospital in Castellon, and to inves-
tigate the relationship with the survival of patients who 
experienced GIF.
Patients and Methods
Patients with stage IIIc and IV ovarian, peritoneal, and 
fallopian tube carcinoma who underwent primary cytore-
duction, with intestinal resections (rectosigmoid, jejunum, 
ileum and/or colon), at the MUAPOS of the University 
General Hospital of Castellon in Spain from January 2013 
to January 2018, were included. All of the patients had an 
Eastern Cooperative Oncology Group (ECOG) Score <3. 
Patients who were at risk of unresectability according to 
the advanced ovarian cancer management guide of the 
MUAPOS10 received neoadjuvant chemotherapy and 
were excluded from this study. A prospective analytical 
study was carried out based on a retrospective analysis of 
the data.
Demographic, clinicopathological, and follow-up data 
were analyzed. Debulking status was defined: Complete 
(Group A): no residual; Optimal (Group B): residual tumor 
<1 cm; Suboptimal (Group C): residual tumor >1 cm. For 
this study, complications grade I–II and grade III–IV were 
categorized in Minor and Major, respectively, according to 
the Clavien-Dindo classification.11 When collecting data 
from complications, cancer-related procedures, ie diagnos-
tic thoracentesis for staging, were not considered. For the 
diagnosis of malnutrition were used anthropometric, clinic 
and laboratory parameters. Mainly studied parameters 
were age, albumin prior to the intervention, peritoneal 
carcinomatosis index, chemotherapy administration and 
tumor staging.
GIF was defined as any exit of material from the 
digestive tract, which can remain in the abdominal cavity 
in the form of a collection (anastomosis leakage) or go 
outside either spontaneously or through a drain (true 
fistula).12 In the same way, GIF was categorized into the 
rectosigmoid anastomosis, related to colonic anastomosis, 
and related to small bowel anastomosis which includes 
genuine small bowel fistulae, gastro-jejunal, duodenal, 
and those related to anastomosis between the colon and 
small bowel.
The patients were staged following the International 
Federation of Obstetrics and Gynecology (FIGO)13 staging 
system, and the quantitative assessment of the carcinoma-
tosis distribution was done following Sugabaker’s 
Peritoneal Carcinomatosis Index (PCI) (categorized in 
1–10, 11–20, >20).14 The PCI was determined at the 
time of surgery by the same surgical team. Patients were 
informed of this study, and written informed consent was 
obtained from all the participants included in the study. 
The Ethics and Clinical Research Committee of the 
General University Hospital in Castellon also gave its 
approval. All procedures performed in this study were 
under the ethical standards of our Hospital and the 1964 
Declaration of Helsinki.
Statistical Analysis
Statistical analysis was directed to compare two groups: 
Presence of GIF vs Absence of GIF. Means and Standard 
deviation were used for summarizing quantitative vari-
ables, counts and percentages for summarizing qualitative 
variables. For univariate statistics, the Mann–Whitney 
test was used to compare groups of quantitative non- 
parametric variables, and CHI-squared or Fisher’s exact 
test to compare qualitative variables. As for the descrip-
tive and univariate statistical analysis of overall and dis-
ease-free survival associated with the event of a GIF, 
Kaplan–Meier curves and Log Rank test were used. 
Medians and 95% Confidence Intervals of survival were 
calculated. To identify the most influential independent 
factors in the appearance of GIF a multivariate analysis 
was performed with all significant and almost significant 
variables from the univariate analysis that has been 
included in a backwards-stepwise model of binary logis-
tic regression, with the condition that those whose p is 
less than 0.05 remain in the final model and more than 
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0.15 are removed. A Network analysis using JASP soft-
ware . JASP (Version 0.13.1) URL = {https://jasp-stats. 
org/} was performed with the most significant risk factors 
(p<0.15) for GIF in the multivariate analysis to show the 
strength of their correlations. The remaining analysis of 
statistical data was performed using the IBM-SPSS soft-
ware version 25 (IBM Corp. Released 2017. IBM SPSS 
Statistics for Windows, Version 25.0. Armonk, NY: IBM 
Corp.). A p-value <0.05 was considered statistically 
significant.
Table 1 Clinicopathological Characteristics of All Patients
Total No Yes P value
n=107 n=95 (89%) n=12 (11%)
Age 60±10.5 60±10.6 62±10.6 0.52
FIGO stage 0.49
III 80 (74.8%) 72 (75.8%) 8 (66.7%)
IV 27 (25.2%) 23 (24.2%) 4 (33.3%)
Charlson 2±2.2 2±2.1 3±2.4 0.36
Charlson category 0.31
CHR0 40 (37.4%) 36 (37.9%) 4 (33.3%)
CHR1–3 33 (30.8%) 31 (32.6%) 2 (16.7%)
CHR4–8 34 (31.8%) 28 (29.5%) 6 (50%)
Preoperative malnutrition 0.090
No 83 (77.6%) 76 (80%) 7 (58.3%)
Yes 24 (22.4%) 19 (20%) 5 (41.7%)
Duration (min) of surgery 440±163 434±162.8 490±162.2 0.26
Operative PCI 14±9.4 13±9.1 20±9.9 0.027
Operative PCI category 0.14
1–10 43 (41.7%) 41 (45%) 2 (16.7%)
11–20 35 (34.0%) 30 (33%) 5 (41.7%)
+20 25 (24.3%) 20 (22%) 5 (41.7%)
Ascitis 0.98
NO 80 (74.8%) 71 (74.7%) 9 (75%)
SI 27 (25.2%) 24 (25.3%) 3 (25%)
Partial bowel obstruction 0.017
No 94 (87.9%) 86 (90.5%) 8 (66.7%)
Yes 13 (12.1%) 9 (9.5%) 4 (33.3%)
Diffuse intestinal or mesos infiltration 0.25
No 85 (79.4%) 77 (81.1%) 8 (66.7%)
Yes 22 (20.6%) 18 (18.9%) 4 (33.3%)
Major invasion of wall or retroperitoneum 0.44
No 96 (89.7%) 86 (90.5%) 10 (83.3%)
Yes 11 (10.3%) 9 (9.5%) 2 (16.7%)
Tumor blocks or retractions 0.42
No 89 (83.2%) 80 (84.2%) 9 (75%)
Yes 18 (16.8%) 15 (15.8%) 3 (25%)
Diaphragmatic invasion 0.81
No 96 (89.7%) 85 (89.5%) 11 (91.7%)
Yes 11 (10.3%) 10 (10.5%) 1 (8.3%)
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Table 2 Principal Procedures Concerning GIF
Total GIF No GIF Yes P value
N=107 N=95 (89%) N=12 (11%)
Peritonectomy 0.06
No 24 (22.4%) 22 (92%) 2 (8%)
Complete 31 (29%) 24 (77%) 7 (23%)
Partial 52 (48.6%) 49 (94%) 3 (6%)
Fulguration or excision of nodules 0.39
No 57 (53.3%) 52 (91%) 5 (9%)
Yes 50 (46.7%) 43 (86%) 7 (14%)
Visceral resection 0.85
No 20 (18.7%) 18 (90%) 2 (10%)
Yes 87 (81.3%) 77 (89%) 10 (11%)
Bowel resection 0.56
No 25 (23.4%) 23 (92%) 2 (8%)
Yes 82 (76.6%) 72 (88%) 10 (12%)
Type of bowel resection 0.13
No 25 (23.4%) 23 (92%) 2 (8%)
Rectum-Sigmoid 15 (14.0%) 15 (100%) 0
Colon 20 (18.7%) 19 (95%) 1 (5%)
Small bowel 22 (20.6%) 19 (86%) 3 (14%)
Multiple 25 (23.4%) 19 (76%) 6 (24%)
Pancreas and/or spleen resection 0.86
No 78 (72.9%) 69 (89%) 9 (11%)
Yes 29 (27.1%) 26 (90%) 3 (10%)
Number of visceral resections 4±3.1 3±2.8 6±4.1 <0.001
Grouped number of visceral resections 0.07
0–2 44 (41.1%) 42 (96%) 2 (4%)
>2 63 (58.9%) 53 (84%) 10 (16%)
Digestive anastomosis 0.06
No 45 (42.1%) 43 (96%) 2 (4%)
Yes 62 (57.9%) 52 (84%) 10 (16%)
Mean digestive anastomosis per patient 0.9±0.1 0.8±0.1 1.3±0.3 0.13
Grouped number of digestive anastomosis per patient 0.20
0–1 86 (80.4%) 78 (91%) 8 (9%)
>1 21 (19.6%) 17 (81%) 4 (19%)
Definitive stoma 0.99
No 89 (83.2%) 79 (89%) 10 (11%)
Yes 18 (16.8%) 16 (89%) 2 (11%)
Lymphadenectomy 0.76
No 49 (45.8%) 43 (88%) 6 (12%)
Yes 58 (54.2%) 52 (90%) 6 (10%)
Operative bleeding cc 1926±887 1856±893 2483±611 0.02
Grouped operative bleeding cc 0.01
0–1000 17 (15.9%) 17 (100%) 0
1000–2000 57 (53.3%) 53 (93%) 4 (7%)
2000–3000 24 (22.4%) 17 (71%) 7 (29%)
+3000 9 (8.4%) 8 (89%) 1 (11%)
(Continued)
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Results
During the study period, 107 patients met the inclusion 
criteria. Given the preexisting interest to study prognostic 
factors related to GIF, the patients were divided into two 
groups: those who did not present this type of complica-
tion (95 patients) and those that did present it (12 patients), 
meaning that 11% of the patients in the study suffered 
from a GIF, 5 (4.5%) and 7 (6.4%) of colorectal and 
small bowel origin, respectively. Of the 12 GIF patients, 
4 patients were true fistulas and 8 anastomosis leakage. 
Table 1 summarizes the clinicopathologic characteristics 
of patients. Table 2 summarizes the characteristics of the 
surgery and outcomes.
The average age in the group of GIF was 62 years, 
compared to the 60 years in the other group. Concerning 
the average duration of surgery, in the group of GIF, it was 
510 minutes, compared to the 450 minutes in the other 
group. GIF incidence was higher (31%) in the presence of 
partial bowel obstruction than in its absence (8%). 
Logically, the percentage of bowel resections in GIF was 
Table 2 (Continued). 
Total GIF No GIF Yes P value
N=107 N=95 (89%) N=12 (11%)
Cytoreduction 0.83
Group A 84 (78.5%) 74 (88%) 10 (12%)
Group B 8 (7.5%) 7 (88%) 1 (12%)
Group C 15 (14%) 14 (93%) 1 (7%)
Cytoreduction 0.54
Group A + B 92 (86%) 81 (88%) 11 (12%)
Group C 15 (14%) 14 (93%) 1 (7%)
Length of stay 22±20.7 19±14.6 49±38.1 <0.001
Grade CLAVIEN-DINDO <0.001
No complication 50 (46.7%) 50 (100%) 0
I 11 (10.3%) 11 (100%) 0
II 13 (12.1%) 13 (100%) 0
III 27 (25.2%) 17 (63%) 10 (37%)
IV 6 (5.7%) 4 (67%) 2 (33%)
Complication grade <0.001
No complication 50 (46.7%) 52 (100%) 0
Minor (I–II) 24 (22.4%) 24 (100%) 0
Major (III–IV) 33 (30.9%) 19 (58%) 12 (42%)
Radiologically or endoscopically intervention <0.001
No 89 (83.2%) 84 (94%) 5 (6%)
Yes 18 (16.8%) 11 (61%) 7 (39%)
Surgical reintervention <0.001
No 90 (84.1%) 86 (96%) 4 (4%)
Yes 17 (15.9%) 9 (53%) 8 (47%)
90 days mortality 0.002
No 103 (96,3%) 92 (91%) 9 (9%)
Yes 4 (3,7%) 3 (50%) 3 (50%)
Disease recurrence 0.95
No 49 (45.8%) 38 (78%) 5 (22%)
Yes 58 (54.2%) 51 (88%) 7 (12%)
Type of disease recurrence 0.88
Peritoneal 16 (27.6%) 14 (88%) 2 (12%)
Metastases 31 (53.4%) 27 (87%) 4 (13%)
Both 11 (19%) 9 (82%) 2 (18%)
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12%, compared to those who did not, which was 8%. 
A total operative PCI mean of 20 was higher in the GIF 
group, while the group that did not present the complica-
tion had a mean of 13. Eighty-three patients (78%) did not 
receive any kind of nutritional support, while 24 (22%) 
received nutritional supplements and/or parenteral nutri-
tion. GIF incidence was higher (21%) in the presence of 
preoperative malnutrition than in its absence (8%).
Principal procedures with anastomotic leakage are 
shown in Table 2. GIF had a higher incidence (23%) when 
complete peritonectomy was performed than when not (8%) 
performed. Multiple intestinal resections were done in the 
majority of cases of GIF, and the number of visceral resec-
tions was more than 2 in the 16% of patients with GIF. 
When blood loss was higher than 2000 mL, it was asso-
ciated with GIF in 29% of patients. The type of cytoreduc-
tion was not associated with the rate of GIF. However, there 
was more incidence of GIF when complete or optimal 
cytoreduction (group A+B) (12%) was performed than 
when it was suboptimal (group C) (7%). No fistula was 
observed when only a colorectal anastomosis was per-
formed. In exclusively colonic anastomoses, we found 1 
(5%) fistula, compared to 3 (14%) in only small bowel 
anastomosis, and 6 (24%) when multiple colorectal and 
small bowel anastomoses were performed. No protective 
stoma was performed.
The number of GIF with or without definitive stoma 
was identical (11%). Significant complications were found 
in 33 (31%) patients, 19 (58%) and 12 (42%) without and 
with GIF. Finally, about the surgical reoperation, it was 
required in 17 (16%) patients, 8 (47%) of those presenting 
a GIF. In those who did not require reoperation, only 4 
(4%) presented GIF.
Multivariate analysis (Table 3) revealed that partial 
bowel obstruction and operative bleeding are the only 
independent risk factors for the appearance of GIF.
Network analysis was performed with the most signifi-
cant risk factors (p <0.15) in the multivariate analysis to 
show the strength of their correlation. The matrix of weights 
correlations and paths are shown in Table 4 and Figure 1.
Cumulative survival analysis using Kaplan-Meier 
curves in the presence or absence of a GIF is shown in 
Figure 2 and Table 5. Median survival was 16 months 
(95% CI 0–35.3) and 37.63 months (95% CI: 29.7–45.4) 
in patients with and without GIF. Median disease-free 
interval in months (Figure 3) was12 (95% CI: 3.8–20.1) 
and19.6 (95% CI: 9.5–29.6). Kaplan-Meier survival curves 
were also constructed, specifying the type of fistula 
(Figure 4). Cumulative survival for Colorectal and small 
bowel fistula and absence of GIF were 16, 6.5 and 37.6 
months, respectively. The disease-free interval for the dif-
ferent types of GIF was 19.6 months (95% CI: 9.5–29.6) 
for the absence of GIF and 12 (95% CI: 0–36.5) and 5.8 
(95% CI: 3.0–8.5) for Colorectal and Small bowel fistulas, 
respectively (Figure 5).
Discussion
In this study, partial bowel obstruction and Operative bleed-
ing are the most important predictive factors in the appear-
ance of GI fistulas in advanced ovarian cancer surgery.
In most studies on peritoneal carcinomatosis originat-
ing from ovarian cancer, it has been observed that the 
Table 3 The Final Model of Backward-Stepwise Logistic Regression Based on the Variables Associated with Univariate Incidence Risk 
of GIF
GIF Odds Ratio CI 95% p value
Operative bleeding (mL) 1.01 1.001–1.022 0.016
Partial bowel obstruction 6.26 1.406–27.671 0.015
Table 4 Network Weights Matrix of Correlations
Charlson Fistula PCI Bleeding Obstruction
Charlson – 0.141 −0.067 −0.163 0.137
Fistula 0.141 – 0.322 0.374 0.457
PCI −0.067 0.322 – 0.221 0.269
Bleeding −0.163 0.374 0.221 – −0.039
Obstruction 0.137 0.457 0.269 −0.039 –
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complete or optimal cytoreduction and platinum-based 
chemotherapy are the only factors that are clearly asso-
ciated with a better survival rate in these patients.4 
According to our MUAPOS database, 86% of our patients 
benefitted from an optimal cytoreduction (Group A+B), 
11% of those developed a gastrointestinal fistula.
Now it is time to distinguish anastomosis leakage from 
fistula in digestive surgery:
Fistula and leaks are terms, which are often used inter-
changeably. However, technically, they are somewhat different 
as we stated in the method section.12 These terms are usually 
employed in the same clinical situations, but their repercussion 
in terms of morbidity is not the same. While anastomosis 
leakage can be resolved frequently with radiological interven-
tion, GIF frequently requires a surgical approach and the 
clinical repercussion is worse for the patient. These different 
definitions are not usually recorded in the literature.12
There is significant variability of GIF/leakages rates in 
the literature which can range from 4% to 20%.15 In our 
data, half of the anastomotic leaks were treated by interven-
tional radiology so they could be considered anastomosis 
leakage instead of real fistulas. Moreover, no GIF fistulas 
were observed in cases of simple colorectal resections. Like 
other authors, we have stated that GIF of colorectal origin is 
more frequent in cases of multiple bowel resections.16
The different types of GIF are more frequently asso-
ciated with two or more visceral resections as we can see 
in our data. As previously described,17,18 the tumor burden 
affects the number of resections performed in patients with 
advanced ovarian cancer so that with a high tumor load, 
quantified as a PCI> 20, more than 3 resections would be 
performed to achieve optimal cytoreduction.
Survival in patients with fistula decreases compared to 
patients without it; surely this is because the hospital stay is 
Figure 1 Network paths of correlations.
Figure 2 Overall survival according to the existence or absence of GIF.
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prolonged and causes patients not to start or to delay the onset 
of chemotherapy and this impacts negatively in 
survival.6–8,16 Moreover, survival among different types of 
GIFs is different. We observe that survival is worse in cases 
of small bowel fistulas. This negative impact on survival is 
probably caused by the impact on the general condition of the 
patient, in the form of dehydration and renal failure, which is 
frequently associated with this type of fistula.19,20
It has been described that malnutrition status is a risk 
factor for anastomosis leakage in ovarian cancer surgery.21 
In our results, five patients (21%) with GIF had malnutri-
tion status at the time of surgery.
The network analysis represents either symmetric relations 
or asymmetric relations between the variables that influence 
the appearance of GIF.22 As we can see in the graph, there is 
a strong correlation between bowel obstruction, bleeding, and 
PCI with the appearance of GIF. It is well known that with 
a high tumor burden quantified as a high PCI number, the risk 
of bowel obstruction increases, and the bleeding produced 
during surgery is higher.17,18,23–25 Multivariate analysis 
revealed that partial bowel obstruction increases six times 
the risk of postoperative digestive fistula, along with an 
increase of operative bleeding. Both variables were the only 
independent risk factors in our study, and they were both 
surrogates variables of the tumor burden and the extent of 
surgery. It is well known that the state of intestinal occlusion or 
suboclusion could generate an inflammatory environment in 
the intestinal wall and therefore more prone to fistulization; in 
this situation, any suture in this area may heal worse.
Strengths of this study include the homogeneous cohort 
of patients, in a tertiary hospital with a uniform approach 
to the treatment of AOC, making it relevant for those at 
highest risk for GIF. One of our main limitations here is 
the retrospective design and analysis of the data, which 
difficult the reproduction in other environments.
Conclusions
The digestive fistula in the postoperative period derives from 
multiple risk factors. In other words, it is multifactorial. 
Specifically, in this study, some factors have more weight 
than others, such as intraoperative bleeding and the presence 
of partial bowel obstruction. But in Table 4 it can be seen that 













GIF 16 4.6–45.2 2.4 1.33–10.02
No GIF 38 28.6–59.8
Global 34 28.2–45.2
Figure 3 Disease-free survival according to the existence or absence of GIF.
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there are other risk factors that are highly correlated with 
fistulas, such as the extent of the disease itself (PCI), and 
comorbidity, and very strikingly, that there are cross- 
correlations (covariance) between them. A maximum effort 
to achieve a complete cytoreduction in a context of a lot of 
peritoneal diseases and in a debilitated patient will suppose 
a highly aggressive surgery that will carry the highest risk of 
postoperative complications, including fistulas and probably 
they, therefore, jeopardize further treatment.
Assuming correct execution of the surgical techni-
que, the best prevention of fistula (and other 
complications) can only consist of planning the inter-
vention aimed at achieving the maximum cytoreduction 
possible with the least possible surgical aggression. 
Probably, combining both things depends to a very 
high degree on the technical training and experience of 
the surgical team.
Data Sharing Statement
The data that support the findings of this study are avail-
able from the corresponding author upon reasonable 
request.
Figure 4 Overall survival for different types of GIF.
Figure 5 Disease-free survival for different types of GIF.
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